IBRX

Immunitybio Inc

(NO DISGNOSTIC SUBSTANCES)
LIFE SCIENCES

Prices are adjusted according to historical splits.

Immunitybio Inc Stock Price

Vitals

Today's Low:
$5.3550
Today's High:
$5.7450
Open Price:
$5.4900
52W Low:
$2.6
52W High:
$8.94
Prev. Close:
$5.4900
Volume:
1197222

Company Statistics

Market Cap.:
$2.150 billion
Book Value:
None
Revenue TTM:
$0.001 billion
Operating Margin TTM:
-63534%
Gross Profit TTM:
$0.001 billion
Gross Profit TTM:
$0.001 billion
Profit Margin:
0%
Return on Assets TTM:
-71.1%
Return on Equity TTM:
0%

Company Profile

Immunitybio Inc had its IPO on 2015-07-28 under the ticker symbol IBRX.

The company operates in the LIFE SCIENCES sector and (NO DISGNOSTIC SUBSTANCES) industry. Immunitybio Inc has a staff strength of 0 employees.

Stock update

Shares of Immunitybio Inc opened at $5.49 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $5.36 - $5.75, and closed at $5.37.

This is a -2.19% slip from the previous day's closing price.

A total volume of 1,197,222 shares were traded at the close of the day’s session.

In the last one week, shares of Immunitybio Inc have increased by +7.4%.

Immunitybio Inc's Key Ratios

Immunitybio Inc has a market cap of $2.150 billion, indicating a price to book ratio of - and a price to sales ratio of 4256.7.

In the last 12-months Immunitybio Inc’s revenue was $0.001 billion with a gross profit of $0.001 billion and an EBITDA of $-0.305 billion. The EBITDA ratio measures Immunitybio Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Immunitybio Inc’s operating margin was -63534% while its return on assets stood at -71.1% with a return of equity of 0%.

In Q2, Immunitybio Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 89.7%.

Immunitybio Inc’s PE and PEG Ratio

Forward PE
-
Trailing PE
-
PEG
None

Its diluted EPS in the last 12-months stands at $-0.941 per share while it has a forward price to earnings multiple of - and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Immunitybio Inc’s profitability.

Immunitybio Inc stock is trading at a EV to sales ratio of 5749.51 and a EV to EBITDA ratio of -8.65. Its price to sales ratio in the trailing 12-months stood at 4256.7.

Immunitybio Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Immunitybio Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Immunitybio Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Immunitybio Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Immunitybio Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Immunitybio Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$5.37
52-Week High
$8.94
52-Week Low
$2.6
Analyst Target Price
$9

Immunitybio Inc stock is currently trading at $5.37 per share. It touched a 52-week high of $8.94 and a 52-week low of $8.94. Analysts tracking the stock have a 12-month average target price of $9.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Immunitybio Inc

The stock symbol (also called stock or share ticker) of Immunitybio Inc is IBRX

The IPO of Immunitybio Inc took place on 2015-07-28

Similar Industry Stocks ((NO DISGNOSTIC SUBSTANCES))

Last Price
Chg
Chg%
$4.67
-0.16
-3.31%
$0.83
-0.06
-6.68%
$8.9
-0.47
-5.02%
$1.48
-0.05
-3.27%
$1.93
0.09
+4.89%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
$0.02
0.01
+100%
Oi S.A (OIBR-C)
$0
0
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

ImmunityBio, Inc., an immunotherapy company, develops a memory T-cell cancer vaccine to fight multiple types of tumors without the use of high-dose chemotherapy.

Address

3530 JOHN HOPKINS COURT, SAN DIEGO, CA, US